Norway Savings Bank Gilead Sciences, Inc. Transaction History

Norway Savings Bank

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 08, 2022	SELL	$57.92 - $72.58 $1,448 - $1,814	-25 Reduced 3.87%	621 $37,000
Q4 2020 Jan 13, 2021	BUY	$56.65 - $64.55 $23,396 - $26,659	413 Added 177.25%	646 $38,000
Q3 2020 Oct 14, 2020	SELL	$62.1 - $78.08 $6,210 - $7,808	-100 Reduced 30.03%	233 $15,000
Q2 2020 Jul 07, 2020	BUY	$72.34 - $84.0 $1,446 - $1,680	20 Added 6.39%	333 $26,000
Q1 2020 Apr 14, 2020	BUY	$62.63 - $80.22 $6,263 - $8,022	100 Added 46.95%	313 $23,000
Q3 2019 Oct 22, 2019	SELL	$62.51 - $69.0 $15,627 - $17,250	-250 Reduced 54.0%	213 $13,000
Q3 2018 Oct 16, 2018	BUY	$71.28 - $78.92 $17,107 - $18,940	240 Added 107.62%	463 $36,000
Q1 2018 Apr 10, 2018	BUY	$72.84 - $88.8 $13,839 - $16,872	190 Added 575.76%	223 $17,000
Q3 2017 Oct 20, 2017	BUY	$72.11 - $85.47 $2,379 - $2,820	33	33 $3,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Norway Savings Bank, based on Form 13F filings with the SEC.

Stay updated on Norway Savings Bank with notifications on news.